Company / Assets per Share
BIOCRYST PHARMACEUTICALS INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.35
FY2025
5-year range
$2.35 / $3.28
FY2021-FY2025
Trend
-0.9%
vs FY2024
Sector context
#186 of 210
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's assets per share of $2.35 is lower than 89% of companies in the Health Care sector (FY2025). Assets per Share has declined for 4 consecutive years, from $3.28 in FY2021 to $2.35 in FY2025.
Based on SEC 10-K filings.
2.35 in FY2025 with a 5-year CAGR of +3.3%.
Declined from $2.69 to $2.35 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -7.4%
- 5-Year CAGR
- +3.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 210This company $2.35 Sector average $296.79
▼
-99.2% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 0.9% year-over-year.
- Ranks #186 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.35 | -0.9% |
| FY2024 | $2.37 | -11.8% |
| FY2023 | $2.69 | -9.1% |
| FY2022 | $2.96 | -9.9% |
| FY2021 | $3.28 | +64.1% |
| FY2020 | $2.00 | +32.0% |
| FY2019 | $1.52 | +6.5% |
| FY2018 | $1.42 | -41.1% |
| FY2017 | $2.42 | +97.3% |
| FY2016 | $1.22 | -28.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026